Neurotech Historical Income Statement

Stocks . Australia . 
Stock . Neurotech International
NTI Stock   0.03  0  5.71%   
Historical analysis of Neurotech International income statement accounts such as Gross Profit of 105.6 K can show how well Neurotech International performed in making a profits. Evaluating Neurotech International income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Neurotech International's future profits or losses.
Cash Flow   Balance Sheet     Income Statement
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Neurotech International latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Neurotech International is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Neurotech Income Statement Analysis

Neurotech International Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Neurotech International shareholders. The income statement also shows Neurotech investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details

Neurotech International Income Statement Chart

At this time, Neurotech International's Selling General Administrative is comparatively stable compared to the past year. Total Revenue is likely to gain to about 226 K in 2025, whereas Net Loss is likely to drop (881.4 K) in 2025.
Selling General Administrative  Total Revenue  Research Development  
Add Fundamental

Total Revenue

Total revenue comprises all receipts Neurotech International generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.
Most accounts from Neurotech International's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Neurotech International current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Neurotech International's Selling General Administrative is comparatively stable compared to the past year. Total Revenue is likely to gain to about 226 K in 2025, whereas Net Loss is likely to drop (881.4 K) in 2025.
 2021 2022 2023 2025 (projected)
Cost Of Revenue573.5K1.7K7.8K108.9K
Research Development2.6M6.5M5.2M27.0K

Neurotech International income statement Correlations

Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income
Income Tax Expense
Interest Income
Depreciation And Amortization
Selling And Marketing Expenses
Ebitda
Net Interest Income
Reconciled Depreciation
Interest Expense
-0.23-0.17-0.28-0.250.280.260.270.280.23-0.310.270.10.260.190.77-0.12-0.10.44-0.880.03
Selling General Administrative
-0.23-0.380.230.54-0.38-0.31-0.360.34-0.310.59-0.56-0.77-0.37-0.250.1-0.110.05-0.570.39-0.35
Total Revenue
-0.17-0.38-0.02-0.60.50.430.2-0.490.24-0.550.530.440.42-0.01-0.010.280.080.020.18-0.08
Gross Profit
-0.280.23-0.020.12-0.150.11-0.060.12-0.980.32-0.020.290.07-0.150.140.05-0.58-0.440.470.02
Other Operating Expenses
-0.250.54-0.60.12-0.96-0.92-0.880.76-0.250.98-0.98-0.56-0.93-0.69-0.260.4-0.12-0.580.17-0.34
Operating Income
0.28-0.380.5-0.15-0.960.940.9-0.750.26-0.950.950.40.960.680.32-0.480.120.61-0.170.36
Net Income From Continuing Ops
0.26-0.310.430.11-0.920.940.9-0.63-0.02-0.850.940.460.990.670.42-0.51-0.120.48-0.090.27
Ebit
0.27-0.360.2-0.06-0.880.90.9-0.70.1-0.860.890.360.920.910.3-0.760.090.61-0.150.42
Research Development
0.280.34-0.490.120.76-0.75-0.63-0.7-0.230.76-0.74-0.41-0.67-0.620.320.38-0.46-0.49-0.23-0.59
Cost Of Revenue
0.23-0.310.24-0.98-0.250.26-0.020.1-0.23-0.430.14-0.190.020.15-0.140.020.580.43-0.42-0.04
Total Operating Expenses
-0.310.59-0.550.320.98-0.95-0.85-0.860.76-0.43-0.95-0.5-0.87-0.69-0.210.39-0.23-0.680.29-0.37
Income Before Tax
0.27-0.560.53-0.02-0.980.950.940.89-0.740.14-0.950.640.960.660.28-0.390.010.61-0.190.41
Total Other Income Expense Net
0.1-0.770.440.29-0.560.40.460.36-0.41-0.19-0.50.640.480.15-0.020.21-0.230.39-0.150.45
Net Income
0.26-0.370.420.07-0.930.960.990.92-0.670.02-0.870.960.480.680.38-0.52-0.110.54-0.10.34
Income Tax Expense
0.19-0.25-0.01-0.15-0.690.680.670.91-0.620.15-0.690.660.150.680.17-0.90.280.51-0.130.39
Interest Income
0.770.1-0.010.14-0.260.320.420.30.32-0.14-0.210.28-0.020.380.17-0.23-0.43-0.03-0.41-0.33
Depreciation And Amortization
-0.12-0.110.280.050.4-0.48-0.51-0.760.380.020.39-0.390.21-0.52-0.9-0.23-0.14-0.28-0.03-0.21
Selling And Marketing Expenses
-0.10.050.08-0.58-0.120.12-0.120.09-0.460.58-0.230.01-0.23-0.110.28-0.43-0.140.31-0.130.36
Ebitda
0.44-0.570.02-0.44-0.580.610.480.61-0.490.43-0.680.610.390.540.51-0.03-0.280.31-0.640.73
Net Interest Income
-0.880.390.180.470.17-0.17-0.09-0.15-0.23-0.420.29-0.19-0.15-0.1-0.13-0.41-0.03-0.13-0.64-0.21
Reconciled Depreciation
0.03-0.35-0.080.02-0.340.360.270.42-0.59-0.04-0.370.410.450.340.39-0.33-0.210.360.73-0.21
Click cells to compare fundamentals

Neurotech International Account Relationship Matchups

High Positive Relationship

Net Income
+ 0.99
Net Income From Continuing Ops
Total Operating Expenses
+ 0.98
Other Operating Expenses
Net Income
+ 0.96
Operating Income
Net Income
+ 0.96
Income Before Tax
Income Before Tax
+ 0.95
Operating Income
Net Income From Continuing Ops
+ 0.94
Operating Income

High Negative Relationship

Income Before Tax
- 0.98
Other Operating Expenses
Cost Of Revenue
- 0.98
Gross Profit
Operating Income
- 0.96
Other Operating Expenses
Income Before Tax
- 0.95
Total Operating Expenses
Total Operating Expenses
- 0.95
Operating Income
Net Income
- 0.93
Other Operating Expenses

Neurotech International income statement Accounts

202020212022202320242025 (projected)
Selling General Administrative659.8K670.0K710.3K948.8K2.4M1.1M
Total Revenue77.4K206.1K38.3K6.0K2.0K226.0K
Gross Profit(546.4K)(238.7K)(535.2K)4.2K(5.9K)105.6K
Other Operating Expenses1.3M7.7M4.0M9.0M8.8M192.6K
Operating Income(1.3M)(7.4M)(3.9M)(9.0M)(5.6M)(952.4K)
Net Income From Continuing Ops(1.7M)(7.4M)(3.4M)(7.8M)(5.1M)(881.4K)
Ebit(1.3M)(14.9M)(3.4M)(9.0M)(8.2M)(952.4K)
Cost Of Revenue623.8K444.9K573.5K1.7K7.8K108.9K
Total Operating Expenses723.5K7.2M3.4M9.0M8.8M1.1M
Income Before Tax(1.7M)(7.4M)(3.9M)(9.0M)(8.2M)(881.4K)
Total Other Income Expense Net(443.5K)55.2K(581.4K)(1.2M)(2.7M)71.0K
Net Income Applicable To Common Shares(1.7M)(7.4M)(3.4M)(7.8M)(755.5K)(793.2K)
Net Income(1.7M)(7.4M)(3.4M)(7.8M)(5.1M)(881.4K)
Income Tax Expense(2.0K)(2.0)(7.4M)(569.3K)(1.2M)(3.2M)
Interest Income135.0486.059.6K158.2K181.9K191.0K
Depreciation And Amortization7.4M588.01.7K583.0670.45636.93
Selling And Marketing Expenses12.5K12.5K10.9K379.0341.1324.05
Ebitda(7.4M)(3.4M)(9.0M)(8.2M)(7.4M)(7.8M)
Net Interest Income(1.6K)(883.0)59.6K158.2K181.9K191.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Neurotech Stock Analysis

When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY